the advantage of adcs for the treatment of brain metastases
Published 2 years ago • 92 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
0:47
systemic therapy for treating brain metastases
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
2:54
safety and efficacy of skb264 for the treatment of advanced or metastatic solid tumors
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
2:07
emerging toxicities associated with adcs
-
1:24
adcs in lung cancer treatment
-
2:30
the future of antibody-drug conjugates in urothelial cancer
-
13:18
updates in the management of lung cancer with adcs
-
6:51
adcs for her2 and her2-low breast cancer
-
4:19
advantages & concerns associated with the use of adc-based conditioning in sct recipients
-
2:07
adcs: is chemotherapy dead?
-
0:46
antibody-drug conjugates in gynecological cancers
-
2:03
recent antibody-drug conjugate approvals in gynecologic malignancies
-
1:58
what’s next for antibody drug conjugates in urothelial carcinoma?
-
1:33
antibody-drug conjugates (adcs) in nsclc
-
0:31
exciting developments in adcs for bc presented at esmo breast 2022
-
2:26
exploring antibody-drug conjugates (adcs) in lung cancer
-
2:30
new antibody-drug conjugates for lymphoma
-
0:51
findings with the antibody drug conjugate d3-gpc2-pbd